Therefore, it is critical to implement a pan-cancer analysis to understand SHC1 copy number, mRNA and protein expression, and to evaluate its association with clinical outcomes and latent molecular mechanisms in cancer therapy. The gene discussed is SHC1; the disease is cancer.